dc.contributor.author
Du, Weinan
dc.contributor.author
Zhang, Luchang
dc.contributor.author
Brett-Morris, Adina
dc.contributor.author
Aguila, Brittany
dc.contributor.author
Kerner, Janos
dc.contributor.author
Hoppel, Charles L.
dc.contributor.author
Puchowicz, Michelle
dc.contributor.author
Serra i Cucurull, Dolors
dc.contributor.author
Herrero Rodríguez, Laura
dc.contributor.author
Rini, Brian I.
dc.contributor.author
Campbell, Steven
dc.contributor.author
Welford, Scott M.
dc.date.issued
2018-01-31T13:44:26Z
dc.date.issued
2018-01-31T13:44:26Z
dc.date.issued
2017-11-24
dc.date.issued
2018-01-31T13:44:26Z
dc.identifier
https://hdl.handle.net/2445/119454
dc.description.abstract
Clear cell renal cell carcinoma (ccRCC) is histologically defined by its lipid and glycogen-rich cytoplasmic deposits. Alterations in the VHL tumor suppressor stabilizing the hypoxiainducible factors (HIFs) are the most prevalent molecular features of clear cell tumors. The significance of lipid deposition remains undefined. We describe the mechanism of lipid deposition in ccRCC by identifying the rate-limiting component of mitochondrial fatty acid transport, carnitine palmitoyltransferase 1A (CPT1A), as a direct HIF target gene. CPT1A is repressed by HIF1 and HIF2, reducing fatty acid transport into the mitochondria, and forcing fatty acids to lipid droplets for storage. Droplet formation occurs independent of lipid source, but only when CPT1A is repressed. Functionally, repression of CPT1A is critical for tumor formation, as elevated CPT1A expression limits tumor growth. In human tumors, CPT1A expression and activity are decreased versus normal kidney; and poor patient outcome associates with lower expression of CPT1A in tumors in TCGA. Together, our studies identify HIF control of fatty acid metabolism as essential for ccRCC tumorigenesis.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Nature Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/s41467-017-01965-8
dc.relation
Nature Communications, 2017, vol. 8, num. 1, p. 1769
dc.relation
https://doi.org/10.1038/s41467-017-01965-8
dc.rights
cc-by (c) Du, Weinan et al., 2017
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Bioquímica i Fisiologia)
dc.subject
Càncer de ronyó
dc.title
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion